detalle del documento
IDENTIFICACIÓN
oai:pubmedcentral.nih.gov:8984...
Tema
ArticlesAutor
Tuzer, Can Karadag, Pelin Yegit, Ozan Eyice, Deniz Oztop, Nida Can, Ali Demir, Semra Coskun, Raif Erdogdu Unal, Derya Olgac, Muge Buyukozturk, Suna Colakoglu, Bahattin Gelincik, AslıLangue
enEditor
OceanSide Publications, Inc.
Categoría
Allergy and Asthma Proceedings
Año
2022
fecha de cotización
10/10/2023
Palabras clave
total rhinitis incs 2b effects and/or 2a covid-19 clinical symptoms nasal 0 cr scores subjectsResumen
BACKGROUND: The clinical effects of intranasal corticosteroids (INC) on nasal symptoms and the clinical course of coronavirus disease 2019 (COVID-19) in subjects with chronic rhinitis (CR) seem unclear.
OBJECTIVE: To evaluate the clinical effects of INCs on nasal symptoms in subjects with CR and with COVID-19.
METHODS: In subjects with CR and diagnosed with COVID-19 at four tertiary centers, quality of life and nasal symptoms were assessed by using the 22-item Sino-Nasal Outcome Test (SNOT-22) and the visual analog scale (VAS), respectively.
In subjects with allergic rhinitis, nasal symptoms were also assessed on the total symptom score-6 (TSS-6) scale.
The subjects were then allocated into two groups according to whether or not they used INCs while infected with the severe acute respiratory syndrome coronavirus 2 (group 1 and group 2, respectively).
The subjects in group 2 were divided into two subgroups according to the use of antihistamines and/or leukotriene receptor antagonist or not (group 2a and group 2b, respectively).
All the scores were compared before and during COVID-19 among the three groups.
RESULTS: A total of 71 subjects (21 in group 1, 24 in group 2a, and 26 in group 2b) were enrolled.
The total scores of the SNOT-22 increased remarkably in all the groups during the infection when compared with the pre–COVID-19 scores (p < 0.001 in each group).
However, the difference between the pre–COVID-19 and COVID-19 values revealed a lower decrease in the senses of smell and/or taste in group 1 than in group 2a and group 2b (p = 0.015, adjusted p = 0.045; and p = 0.001, adjusted p = 0.002, respectively).
There were no significant differences in other COVID-19 findings, VAS, and TSS-6 scores among the groups (all p > 0.05).
CONCLUSION: INCs in subjects with CR seemed protective against the decrease in smell and/or taste observed during COVID-19 and do not aggravate the clinical course of COVID-19.
Tuzer, Can,Karadag, Pelin,Yegit, Ozan,Eyice, Deniz,Oztop, Nida,Can, Ali,Demir, Semra,Coskun, Raif,Erdogdu Unal, Derya,Olgac, Muge,Buyukozturk, Suna,Colakoglu, Bahattin,Gelincik, Aslı, 2022, Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19, OceanSide Publications, Inc.
High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
